Life-Sciences-Europe.com
The European Life Sciences Web Portal

This is a free web portal for the life sciences in Europe and Israel... » read more

Nuvisan to Take Over Bayer Small-Molecule Research in Berlin (2020-02-11)
Nuvisan to establish full-fledged research center with around 400 jobs in Berlin / Transaction to contribute to further strengthening healthcare cluster in Berlin / Bayer to retain significant research activities and headquarters for the company’s Pharmaceuticals D...
ERS Genomics/Aelian Biotechnology: CRISPR License Agreement (2020-02-11)
ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and Aelian Biotechnology (“Aelian”) today announced the signing of a license agreement granting Aelian acces...
Stilla Technologies Raises €20m Series B Round (2020-02-11)
Stilla Technologies, a leading provider of pioneering digital PCR (dPCR) solutions for high-precision genetic analysis, has just raised €20 million ($22 million) in a Series B funding round that brought in a new investor, the Chinese group TUS-Holdings, alongside t...
Bayer & Meiogenix = Plant Breeding & Gemone Editing (2020-02-10)
Bayer and Meiogenix, a biotech company focused on next-generation breeding technologies, announced today a collaboration to advance agricultural research and development by accelerating the development of Meiogenix’s proprietary technologies related to plant breedi...
ERS Genomics: EPO Affirms Key CRISPR-Cas9 Patent (2020-02-10)
ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property held by Dr. Emmanuelle Charpentier, announced today that the European Patent Office (EPO) has rejected arguments filed in opposition to European pat...
Roche: Gantenerumab Phase 2/3 AD Study Misses Endpoint (2020-02-10)
> Primary endpoint was not met in a study sponsored by Washington University; additional analyses are ongoing to understand the totality of the data > Data from study in people with or at-risk for autosomal dominant Alzheimer’s disease will be presented at the A...
Azafaros Completes €25m Series A Round, Led by Forbion (2020-02-06)
Financing round led by Forbion with participation from BioMedPartners and founding investor BioGeneration Ventures Azafaros B.V. announced today the successful closing of its Series A financing round raising EUR 25 million (approximately USD 28 million). Thi...
Lunaphore Raises CHF23m Series C, Led by PHC Holdings (2020-02-06)
Lunaphore Technologies SA, a Swiss life-sciences company developing innovative next-generation equipment for cancer research and tissue diagnostics, announces the first closing of its Series C funding, amounting to CHF 23M. The round was led by the Japanese strateg...
MaaT Pharma: €18m Series B for Microbiome Therapeutics (2020-02-05)
Funding enables expansion of clinical program to include additional cancer indications and development of a capsule formulation of MaaT Pharma’s full-ecosystem therapeutic MaaT Pharma announced today an €18 million Series B financing round including a microbio...
MorphoSys: Expanded Access Program for Tafasitamab in US (2020-02-04)
MorphoSys AG (FSE: MOR; Prime Standard Segment; MDAX & TecDAX; NASDAQ: MOR) announced today the initiation of an expanded access program (EAP) in the U.S. for tafasitamab, an investigational anti-CD19 antibody. The EAP may provide access to tafasitamab for use in p...

» Show all News!"

Life-Sciences-Europe.com is your doorway to the European life sciences!

[LSE] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in Europe and Israel.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSE] is 100% Made in Germany!

Start here with the latest News!

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]